Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 HKD | +0.88% | -5.79% | -21.92% |
Apr. 03 | Ascletis Discontinues Trials of FXR Agonist for Biliary Cholangitis, NASH and Hepatitis B Virus | MT |
Apr. 03 | Ascletis Pharma Inc. Announces Strategic Decisions on FXR Agonist ASC42 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.07B 148M 1.15B |
---|---|---|---|---|---|
Net income 2024 * | -219M -30.22M -236M | Net income 2025 * | -242M -33.39M -261M | EV / Sales 2024 * | - |
Net cash position 2024 * | 2B 276M 2.16B | Net cash position 2025 * | 1.7B 234M 1.83B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.22
x | P/E ratio 2025 * |
-4.65
x | Employees | 219 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 27.46% |
1 day | +0.88% | ||
1 week | -5.79% | ||
Current month | -5.79% | ||
1 month | -18.57% | ||
3 months | -28.75% | ||
6 months | -32.94% | ||
Current year | -21.92% |
Managers | Title | Age | Since |
---|---|---|---|
Jinzi Wu
CEO | Chief Executive Officer | 61 | - |
Yan Yuemei
CTO | Chief Tech/Sci/R&D Officer | - | - |
Handan He
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jinzi Wu
CEO | Chief Executive Officer | 61 | - |
Jiong Gu
BRD | Director/Board Member | 51 | 18-03-31 |
Chief Operating Officer | 50 | 19-03-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.78% | 4 M€ | -27.92% | ||
0.00% | 32 M€ | +4.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.14 | +0.88% | 308,000 |
24-06-06 | 1.13 | -0.88% | 1,160,000 |
24-06-05 | 1.14 | -0.87% | 786,000 |
24-06-04 | 1.15 | +3.60% | 734,000 |
24-06-03 | 1.11 | -8.26% | 2,246,000 |
Delayed Quote Hong Kong S.E., June 07, 2024 at 04:09 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.92% | 148M | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.20% | 26.66B | |
-16.31% | 15.32B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B | |
+5.62% | 9.06B |
- Stock Market
- Equities
- 1672 Stock